Andrew Cheng, DPM
Podiatrist · Honolulu, HINPI 1376040162
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,494 of the $2,172 with a category attached, or 68.8%. It is spread thinly across 14 manufacturers, the largest accounting for just 22.2%. Reporting peaked in 2023 at $924 and has fallen 95.0% since, to $46 in 2025.
Across 32 payments — averaging $67.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$482
- Elevate Surgical Co$431
- Arthrex$410
- Paragon 28, Inc.$250
- Integra Lifesciences Corporation$120
- Smith+Nephew$108
- plus $371 from 8 others
What the payments were for
- Travel & lodging$65230%
- Food & beverage$1,49469%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $482 |
| Elevate Surgical Co | 1 | $431 |
| Arthrex | 5 | $410 |
| Paragon 28, Inc. | 2 | $250 |
| Integra Lifesciences Corporation | 2 | $120 |
| Smith+Nephew | 2 | $108 |
| Gilead | 1 | $104 |
| Solventum Corporation | 1 | $66 |
| Bone Support Inc. | 1 | $62 |
| Orthofix Medical, Inc. | 2 | $46 |
| Bioventus LLC | 1 | $28 |
| Resmed Corp | 1 | $26 |
| Evolution Surgical, Inc | 1 | $22 |
| Treace Medical Concepts, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few podiatrist providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 66 | $4,407 |
| Colchicine | 12 | $378 |
| Doxycycline Hyclate | 28 | $310 |
| Meloxicam | 33 | $283 |
| Cephalexin | 18 | $154 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Honolulu
- Kenson MiyakiHonolulu$1K
- Christopher YeeHonolulu$320
- Linda HoHonolulu$169
- Antonio FeriaHonolulu$149
- Ricky SukitaHonolulu$129
- Michelle TsouHonolulu$96
- Theodore YorkHonolulu$21
- Ken SakudaHonolulu$20
- Andrew YunHonolulu$14
- Robert AkiEwa Beach$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.